Faculty Collaboration Database

1. Drake VJ, Koprowski SL, Lough JW, Smith SM. Gastrulating chick embryo as a model for evaluating teratogenicity: a comparison of three approaches. Birth Defects Res A Clin Mol Teratol. 2006 Jan;76(1):66-71.

2. Nelson TJ, Ge ZD, Van Orman J, Barron M, Rudy-Reil D, Hacker TA, Misra R, Duncan SA, Auchampach JA, Lough JW. Improved cardiac function in infarcted mice after treatment with pluripotent embryonic stem cells. Anat Rec A Discov Mol Cell Evol Biol. 2006 Nov;288(11):1216-24. PMCID: PMC2566533

3. Van Orman JR, Weihrauch D, Warltier DC, Lough J. Myocardial interstitial fluid inhibits proliferation and cardiomyocyte differentiation in pluripotent embryonic stem cells. Am J Physiol Heart Circ Physiol. 2009 Oct;297(4):H1369-76. PMCID: PMC2770771

4. Si-Tayeb K, Noto FK, Sepac A, Sedlic F, Bosnjak ZJ, Lough JW, Duncan SA. Generation of human induced pluripotent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors. BMC Dev Biol. 2010 Aug 03;10:81. PMCID: PMC2923111

5. Sepac A, Si-Tayeb K, Sedlic F, Barrett S, Canfield S, Duncan SA, Bosnjak ZJ, Lough JW. Comparison of cardiomyogenic potential among human ESC and iPSC lines. Cell Transplant. 2012;21(11):2523-30. PMCID: PMC3522765

6. Xiao Y, Nagai Y, Deng G, Ohtani T, Zhu Z, Zhou Z, Zhang H, Ji MQ, Lough JW, Samanta A, Hancock WW, Greene MI. Dynamic interactions between TIP60 and p300 regulate FOXP3 function through a structural switch defined by a single lysine on TIP60. Cell Rep. 2014 Jun 12;7(5):1471-1480. PMCID: PMC4064594

7. Kim MS, Horst A, Blinka S, Stamm K, Mahnke D, Schuman J, Gundry R, Tomita-Mitchell A, Lough J. Activin-A and Bmp4 levels modulate cell type specification during CHIR-induced cardiomyogenesis. PLoS One. 2015;10(2):e0118670. PMCID: PMC4338295

8. Gao Y, Hamers N, Rakhshandehroo M, Berger R, Lough J, Kalkhoven E. Allele compensation in tip60+/- mice rescues white adipose tissue function in vivo. PLoS One. 2014;9(5):e98343. PMCID: PMC4037199

9. Van Orman JR, Si-Tayeb K, Duncan SA, Lough J. Induction of cardiomyogenesis in human embryonic stem cells by human embryonic stem cell-derived definitive endoderm. Stem Cells Dev. 2012 Apr 10;21(6):987-94. PMCID: PMC3315759

10. Gehrking KM, Andresen JM, Duvick L, Lough J, Zoghbi HY, Orr HT. Partial loss of Tip60 slows mid-stage neurodegeneration in a spinocerebellar ataxia type 1 (SCA1) mouse model. Hum Mol Genet. 2011 Jun 01;20(11):2204-12. PMCID: PMC3090197

11. Sepac A, Sedlic F, Si-Tayeb K, Lough J, Duncan SA, Bienengraeber M, Park F, Kim J, Bosnjak ZJ. Isoflurane preconditioning elicits competent endogenous mechanisms of protection from oxidative stress in cardiomyocytes derived from human embryonic stem cells. Anesthesiology. 2010 Oct;113(4):906-16. PMCID: PMC2945423

12. Rufer ES, Hacker TA, Flentke GR, Drake VJ, Brody MJ, Lough J, Smith SM. Altered cardiac function and ventricular septal defect in avian embryos exposed to low-dose trichloroethylene. Toxicol Sci. 2010 Feb;113(2):444-52. PMCID: PMC2807037

13. Zhao M, Barron MR, Li Z, Koprowski S, Hall CL, Lough J. Making stem cells infarct avid. Cell Transplant. 2010;19(2):245-50.

14. Hu Y, Fisher JB, Koprowski S, McAllister D, Kim MS, Lough J. Homozygous disruption of the Tip60 gene causes early embryonic lethality. Dev Dyn. 2009 Nov;238(11):2912-21. PMCID: PMC2801416

15. Li Z, Barron MR, Lough J, Zhao M. Rapid single-step separation of pluripotent mouse embryonic stem cells from mouse feeder fibroblasts. Stem Cells Dev. 2008 Apr;17(2):383-7.

16. Gorrini C, Squatrito M, Luise C, Syed N, Perna D, Wark L, Martinato F, Sardella D, Verrecchia A, Bennett S, Confalonieri S, Cesaroni M, Marchesi F, Gasco M, Scanziani E, Capra M, Mai S, Nuciforo P, Crook T, Lough J, Amati B. Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response. Nature. 2007 Aug 30;448(7157):1063-7.

17. Drake VJ, Koprowski SL, Hu N, Smith SM, Lough J. Cardiogenic effects of trichloroethylene and trichloroacetic acid following exposure during heart specification of avian development. Toxicol Sci. 2006 Nov;94(1):153-62.

18. Nelson TJ, Ge ZD, Van Orman J, Barron M, Rudy-Reil D, Hacker TA, Misra R, Duncan SA, Auchampach JA, Lough JW. Improved cardiac function in infarcted mice after treatment with pluripotent embryonic stem cells. Anat Rec A Discov Mol Cell Evol Biol. 2006 Nov;288(11):1216-24. PMCID: PMC2566533

19. Kim MS, Merlo X, Wilson C, Lough J. Co-activation of atrial natriuretic factor promoter by Tip60 and serum response factor. J Biol Chem. 2006 Jun 02;281(22):15082-9.

20. Drake VJ, Koprowski SL, Lough J, Hu N, Smith SM. Trichloroethylene exposure during cardiac valvuloseptal morphogenesis alters cushion formation and cardiac hemodynamics in the avian embryo. Environ Health Perspect. 2006 Jun;114(6):842-7. PMCID: PMC1480523

21. Krippendorf BB, Lough J. Complete and rapid switch from light microscopy to virtual microscopy for teaching medical histology. Anat Rec B New Anat. 2005 Jul;285(1):19-25.

22. Barron MR, Belaguli NS, Zhang SX, Trinh M, Iyer D, Merlo X, Lough JW, Parmacek MS, Bruneau BG, Schwartz RJ. Serum response factor, an enriched cardiac mesoderm obligatory factor, is a downstream gene target for Tbx genes. J Biol Chem. 2005 Mar 25;280(12):11816-28.

23. Rudy-Reil D, Lough J. Avian precardiac endoderm/mesoderm induces cardiac myocyte differentiation in murine embryonic stem cells. Circ Res. 2004 Jun 25;94(12):e107-16.

24. Flentke GR, Baker MW, Docterman KE, Power S, Lough J, Smith SM. Microarray analysis of retinoid-dependent gene activity during rat embryogenesis: increased collagen fibril production in a model of retinoid insufficiency. Dev Dyn. 2004 Apr;229(4):886-98.

25. Lough JW. What's hot in anatomy: hematopoietic progenitor cells and myocardial repair. Anat Rec B New Anat. 2003 Sep;274(1):147.

26. Wendler CC, Schmoldt A, Flentke GR, Case LC, Quadro L, Blaner WS, Lough J, Smith SM. Increased fibronectin deposition in embryonic hearts of retinol-binding protein-null mice. Circ Res. 2003 May 02;92(8):920-8. PMCID: PMC3752713

27. Zhu X, McAllister D, Lough J. Inhibition of the cardiac alpha-actin gene in embryonic cardiac myocytes by dominant-negative serum response factor. Anat Rec A Discov Mol Cell Evol Biol. 2003 Apr;271(2):315-21.

28. McAllister D, Merlo X, Lough J. Characterization and expression of the mouse tat interactive protein 60 kD (TIP60) gene. Gene. 2002 May 01;289(1-2):169-76.

29. Lough JW. Transient expression of TIP60 protein during early chick heart development. Dev Dyn. 2002 Mar;223(3):419-25.

30. Franciosi JP, Bolender DL, Lough J, Kolesari GL. FGF-2-induced imbalance in early embryonic heart cell proliferation: a potential cause of late cardiovascular anomalies. Teratology. 2000 Oct;62(4):189-94.

31. Gont L, Lough J. Differential expression of cSmad1 and cSmad5 in the primitive streak during chick embryo gastrulation. Anat Rec. 2000 Sep 01;260(1):102-5.

32. Barron M, Gao M, Lough J. Requirement for BMP and FGF signaling during cardiogenic induction in non-precardiac mesoderm is specific, transient, and cooperative. Dev Dyn. 2000 Jun;218(2):383-93.

33. Lough J, Sugi Y. Endoderm and heart development. Dev Dyn. 2000 Apr;217(4):327-42.

34. Zhu X, Sasse J, Lough J. Evidence that FGF receptor signaling is necessary for endoderm-regulated development of precardiac mesoderm. Mech Ageing Dev. 1999 Apr 01;108(1):77-85.

35. Barron M, McAllister D, Smith SM, Lough J. Expression of retinol binding protein and transthyretin during early embryogenesis. Dev Dyn. 1998 Jul;212(3):413-22.

36. Watkins BP, Bolender DL, Lough J, Kolesari GL. Teratogenic effects of implanting fibroblast growth factor-2-soaked beads in the cardiac region of the stage 24 chick embryo. Teratology. 1998 Mar;57(3):140-5.

37. Zhu X, Sasse J, McAllister D, Lough J. Evidence that fibroblast growth factors 1 and 4 participate in regulation of cardiogenesis. Dev Dyn. 1996 Dec;207(4):429-38.

38. McCormick KM, Dahms NM, Lough J. Insulin-like growth factor-II/mannose-6-phosphate receptor expression during early heart development. Dev Dyn. 1996 Oct;207(2):195-203.

39. Lough J, Barron M, Brogley M, Sugi Y, Bolender DL, Zhu X. Combined BMP-2 and FGF-4, but neither factor alone, induces cardiogenesis in non-precardiac embryonic mesoderm. Dev Biol. 1996 Aug 25;178(1):198-202.

40. Croissant JD, Kim JH, Eichele G, Goering L, Lough J, Prywes R, Schwartz RJ. Avian serum response factor expression restricted primarily to muscle cell lineages is required for alpha-actin gene transcription. Dev Biol. 1996 Jul 10;177(1):250-64.

41. Zhu X, Lough J. Expression of alternatively spliced and canonical basic fibroblast growth factor mRNAs in the early embryo and developing heart. Dev Dyn. 1996 Jun;206(2):139-45.

42. Sugi Y, Lough J. Activin-A and FGF-2 mimic the inductive effects of anterior endoderm on terminal cardiac myogenesis in vitro. Dev Biol. 1995 Apr;168(2):567-74.

43. Schaefer CW. Ecological separation of the human head lice and body lice (Anoplura: Pediculidae). Trans R Soc Trop Med Hyg. 1978;72(6):669-70.

44. Sugi Y, Sasse J, Barron M, Lough J. Developmental expression of fibroblast growth factor receptor-1 (cek-1; flg) during heart development. Dev Dyn. 1995 Feb;202(2):115-25.

45. Sugi Y, Lough J. Anterior endoderm is a specific effector of terminal cardiac myocyte differentiation of cells from the embryonic heart forming region. Dev Dyn. 1994 Jun;200(2):155-62.

46. Sugi Y, Sasse J, Lough J. Inhibition of precardiac mesoderm cell proliferation by antisense oligodeoxynucleotide complementary to fibroblast growth factor-2 (FGF-2). Dev Biol. 1993 May;157(1):28-37.

47. Sugi Y, Lough J. Onset of expression and regional deposition of alpha-smooth and sarcomeric actin during avian heart development. Dev Dyn. 1992 Feb;193(2):116-24.

48. Parlow MH, Bolender DL, Kokan-Moore NP, Lough J. Localization of bFGF-like proteins as punctate inclusions in the preseptation myocardium of the chicken embryo. Dev Biol. 1991 Jul;146(1):139-47.

49. Kokan-Moore NP, Bolender DL, Lough J. Secretion of inhibin beta A by endoderm cultured from early embryonic chicken. Dev Biol. 1991 Jul;146(1):242-5.

50. Wunsch AM, Reinhardt K, Lough J. Normal transitions in synthesis of replacement histones H2A.Z and H3.3 during differentiation of dystrophic myotube cells. A brief note. Mech Ageing Dev. 1991 Jun 28;59(3):299-305.

51. Dawson BA, Herman T, Haas AL, Lough J. Affinity isolation of active murine erythroleukemia cell chromatin: uniform distribution of ubiquitinated histone H2A between active and inactive fractions. J Cell Biochem. 1991 Jun;46(2):166-73.

52. Masuck TM, Taylor AR, Lough J. Arabinosylcytosine-induced accumulation of DNA nicks in myotube nuclei detected by in situ nick translation. J Cell Physiol. 1990 Jul;144(1):12-7.

53. Parlow MH, Haas AL, Lough J. Enrichment of ubiquitinated histone H2A in a low salt extract of micrococcal nuclease-digested myotube nuclei. J Biol Chem. 1990 May 05;265(13):7507-12.

54. Wunsch AM, Lough J. Histone variant patterns during vertebrate embryogenesis and limb development. Cell Differ Dev. 1990 Apr;30(1):19-25.

55. Wunsch AM, Lough J. Histones synthesized at different stages of myogenesis are differentially degraded in myotube cells. J Cell Physiol. 1989 Oct;141(1):97-102.

56. Dawson BA, Herman T, Lough J. Affinity isolation of transcriptionally active murine erythroleukemia cell DNA using a cleavable biotinylated nucleotide analog. J Biol Chem. 1989 Aug 05;264(22):12830-7.

57. Dawson BA, Lough J. Immunocytochemical localization of transient DNA strand breaks in differentiating myotubes using in situ nick-translation. Dev Biol. 1988 Jun;127(2):362-7.

58. Wunsch AM, Haas AL, Lough J. Synthesis and ubiquitination of histones during myogenesis. Dev Biol. 1987 Jan;119(1):85-93.

59. Wunsch AM, Lough J. Modulation of histone H3 variant synthesis during the myoblast-myotube transition of chicken myogenesis. Dev Biol. 1987 Jan;119(1):94-9.

60. Roseman B, Lough J, Houkom E, Herman T. Affinity isolation of transcriptionally active DNA. Biochem Biophys Res Commun. 1986 May 29;137(1):474-9.

61. Multhauf C, Lough J. Interferon-mediated inhibition of differentiation in a murine myoblast cell line. J Cell Physiol. 1986 Feb;126(2):211-5.

62. Lough J, Wrenn DS, Miziorko HM, Auer HE. Differential sensitivity of chicken MM-creatine kinase to trypsin and proteinase-K. Int J Biochem. 1985;17(3):309-18.

63. Lough J. Spermine-induced phosphorylation of myotube histones by endogenous nuclear protein kinases. Exp Cell Res. 1984 Jan;150(1):23-8.

64. Lough J. Declining histone phosphorylation during myogenesis revealed by in vivo and in vitro labeling. Exp Cell Res. 1983 Oct 15;148(2):437-47.

65. Lough J. DNA synthesis and accumulation of acetylated histone in butyrate-treated myogenic cultures. Cell Biol Int Rep. 1981 Jul;5(7):691-8.

66. Lough J, Ingram VM. Change in a nuclear phosphoprotein during in vitro myogenesis. Exp Cell Res. 1978 Jul;114(2):349-56.

67. Lough J, Bischoff R. Differentiation of creatine phosphokinase during myogenesis: quantitative fractionation of isozymes. Dev Biol. 1977 Jun;57(2):330-44.

68. Lough J, Bischoff R. Differential sensitivity to 5-bromodeoxyuridine during the S phase of synchronized myogenic cells. Dev Biol. 1976 Jun;50(2):457-75.

69. Bossen EH, Lough JW Jr, Hansen JL. The effects of chloroquine on chick skeletal muscle in vitro. Toxicol Appl Pharmacol. 1973 Feb;24(2):197-205.

70. Lough JW, Entman ML, Bossen EH, Hansen JL. Calcium accumulation by isolated sarcoplasmic reticulum of skeletal muscle during development in tissue culture. J Cell Physiol. 1972 Dec;80(3):431-6.

71. Feir D, Lough JW Jr. Physiology of the large milkweed bug after laser irradiation. Comp Biochem Physiol. 1969 Feb;28(2):759-64.

72. Fisher JB, Kim MS, Blinka S, Ge ZD, Wan T, Duris C, Christian D, Twaroski K, North P, Auchampach J, Lough J. Stress-induced cell-cycle activation in Tip60 haploinsufficient adult cardiomyocytes. PLoS One. 2012;7(2):e31569. PMCID: PMC3279378

73. Tomita-Mitchell A, Stamm KD, Mahnke DK, Kim MS, Hidestrand PM, Liang HL, Goetsch MA, Hidestrand M, Simpson P, Pelech AN, Tweddell JS, Benson DW, Lough JW, Mitchell ME. Impact of MYH6 variants in hypoplastic left heart syndrome. Physiol Genomics. 2016 Dec 01;48(12):912-921. PMCID: PMC5206387

74. Wang X, Lupton C, Lauth A, Wan TC, Foster P, Patterson M, Auchampach JA, Lough JW. Evidence that the acetyltransferase Tip60 induces the DNA damage response and cell-cycle arrest in neonatal cardiomyocytes. J Mol Cell Cardiol. 2021 Jun;155:88-98. PMCID: PMC8154663

75. Wang X, Lauth A, Wan TC, Lough JW, Auchampach JA. <i>Myh6</i>-driven Cre recombinase activates the DNA damage response and the cell cycle in the myocardium in the absence of loxP sites. Dis Model Mech. 2020 Dec 18;13(12). PMCID: PMC7758623

76. Kim MS, Fleres B, Lovett J, Anfinson M, Samudrala SSK, Kelly LJ, Teigen LE, Cavanaugh M, Marquez M, Geurts AM, Lough JW, Mitchell ME, Fitts RH, Tomita-Mitchell A. Contractility of Induced Pluripotent Stem Cell-Cardiomyocytes With an MYH6 Head Domain Variant Associated With Hypoplastic Left Heart Syndrome Frontiers in Cell and Developmental Biology. 23 June 2020;8.

77. Numata A, Kwok HS, Zhou QL, Li J, Tirado-Magallanes R, Angarica VE, Hannah R, Park J, Wang CQ, Krishnan V, Rajagopalan D, Zhang Y, Zhou S, Welner RS, Osato M, Jha S, Bohlander SK, Göttgens B, Yang H, Benoukraf T, Lough JW, Bararia D, Tenen DG. Lysine acetyltransferase Tip60 is required for hematopoietic stem cell maintenance. Blood. 2020 Oct 08;136(15):1735-1747. PMCID: PMC7544546

78. Fisher JB, Horst A, Wan T, Kim MS, Auchampach J, Lough J. Depletion of Tip60 from In Vivo Cardiomyocytes Increases Myocyte Density, Followed by Cardiac Dysfunction, Myocyte Fallout and Lethality. PLoS One. 2016;11(10):e0164855. PMCID: PMC5074524

79. Chevillard-Briet M, Quaranta M, Grézy A, Mattera L, Courilleau C, Philippe M, Mercier P, Corpet D, Lough J, Ueda T, Fukunaga R, Trouche D, Escaffit F. Interplay between chromatin-modifying enzymes controls colon cancer progression through Wnt signaling. Hum Mol Genet. 2014 Apr 15;23(8):2120-31.

80. Kim MS, Merlo X, Wilson C, Lough J. Erratum: Co-activation of atrial natriuretic factor promoter by Tip60 and serum response factor (Journal of Biological Chemistry (2006) 281, (15082-15089)) Journal of Biological Chemistry. 28 July 2006;281(30):21576.

81. Lough J. Introduction to special issue: Anatomy of the nucleus, based on proceedings of the anatomical record symposium held at EB2005 in San Diego, California, on 4 April 2005 Anatomical Record - Part A Discoveries in Molecular, Cellular, and Evolutionary Biology. July 2006;288(7):663.

82. LOUGH JW, BOLENDER DL, MARKWALD RR. A Culture Model for Cardiac Morphogenesis Annals of the New York Academy of Sciences. April 1990;588(1):421-424.

83. Wunsch AM, Lough J. One and two-dimensional electrophoretic assessment of histone synthesis in differentiating G(o) myotube cells Federation Proceedings. 1984;43(6).

84. Lough J. Modulation of in vitro myogenesis by submillimolar concentrations of sodium butyrate. Cell Differ. 1983 Jan;12(1):41-6.

85. Lough J, Keay S, Sabran JL, Grossberg SE. Inhibition of chicken myogenesis in vitro by partially purified interferon. Biochem Biophys Res Commun. 1982 Nov 16;109(1):92-9.

86. Lough J. Muscle specific traits display differential sensitivity to 5-bromo-2'-deoxyuridine. Cell Differ. 1980 Oct;9(5):247-60.

87. Lough J. Effects of sodium buytrate on histone modification and differentiation in cultured myoblasts European Journal of Cell Biology. 1980;22(1).

88. Keay S, Lough J, Grossberg SE. Interferon inhibits the creatine kinase (CK) isozyme transition during in vitro myogenesis Anatomical Record. 1980;196(3).

89. Lough J, Bischoff R. Effect of 5' bromodeoxyuridine concentration on the emergence of muscle specific parameters during myogenesis in vitro Anatomical Record. 1975;181(2):413.

90. Wang X, Wan TC, Lauth A, Purdy AL, Kulik KR, Patterson M, Lough JW, Auchampach JA. Conditional depletion of the acetyltransferase Tip60 protects against the damaging effects of myocardial infarction. J Mol Cell Cardiol. 2022 Feb;163:9-19. PMCID: PMC8816866

91. Kim MS, Fleres B, Lovett J, Anfinson M, Samudrala SSK, Kelly LJ, Teigen LE, Cavanaugh M, Marquez M, Geurts AM, Lough JW, Mitchell ME, Fitts RH, Tomita-Mitchell A. Contractility of Induced Pluripotent Stem Cell-Cardiomyocytes With an <i>MYH6</i> Head Domain Variant Associated With Hypoplastic Left Heart Syndrome. Front Cell Dev Biol. 2020;8:440. PMCID: PMC7324479

92. Auchampach J, Han L, Huang GN, Kühn B, Lough JW, O'Meara CC, Payumo AY, Rosenthal NA, Sucov HM, Yutzey KE, Patterson M. Measuring cardiomyocyte cell-cycle activity and proliferation in the age of heart regeneration. Am J Physiol Heart Circ Physiol. 2022 Apr 01;322(4):H579-H596. PMCID: PMC8934681

93. Anfinson M, Fitts RH, Lough JW, James JM, Simpson PM, Handler SS, Mitchell ME, Tomita-Mitchell A. Significance of α-Myosin Heavy Chain (MYH6) Variants in Hypoplastic Left Heart Syndrome and Related Cardiovascular Diseases Journal of Cardiovascular Development and Disease. May 2022;9(5).

94. Thareja SK, Frommelt MA, Lincoln J, Lough JW, Mitchell ME, Tomita-Mitchell A. A Systematic Review of Ebstein's Anomaly with Left Ventricular Noncompaction. J Cardiovasc Dev Dis. 2022 Apr 13;9(4). PMCID: PMC9031964

95. Thareja SK, Anfinson M, Cavanaugh M, Kim MS, Lamberton P, Radandt J, Brown R, Liang HL, Stamm K, Afzal MZ, Strande J, Frommelt MA, Lough JW, Fitts RH, Mitchell ME, Tomita-Mitchell A. Altered contractility, Ca²⁺ transients, and cell morphology seen in a patient-specific iPSC-CM model of Ebstein's anomaly with left ventricular noncompaction. Am J Physiol Heart Circ Physiol. 2023 Jul 01;325(1):H149-H162. PMCID: PMC10312315

96. Puzyrenko A, Jacobs ER, Padilla N, Devine A, Aljadah M, Gantner BN, Pan AY, Lai S, Dai Q, Rubenstein JC, North PE, Simpson PM, Willoughby RE, O'Meara CC, Flinn MA, Lough JW, Ibrahim EH, Zheng Z, Sun Y, Felix J, Hunt BC, Ross G, Rui H, Benjamin IJ. Collagen-Specific HSP47⁺ Myofibroblasts and CD163⁺ Macrophages Identify Profibrotic Phenotypes in Deceased Hearts With SARS-CoV-2 Infections. J Am Heart Assoc. 2023 Feb 21;12(4):e027990. PMCID: PMC10111490

97. Wang X, Wan TC, Kulik KR, Lauth A, Smith BC, Lough JW, Auchampach JA. Pharmacological inhibition of the acetyltransferase Tip60 mitigates myocardial infarction injury. Dis Model Mech. 2023 May 01;16(5). PMCID: PMC9672930

98. Anfinson M, Fitts RH, Lough JW, James JM, Simpson PM, Handler SS, Mitchell ME, Tomita-Mitchell A. Significance of α-Myosin Heavy Chain (<i>MYH6</i>) Variants in Hypoplastic Left Heart Syndrome and Related Cardiovascular Diseases. J Cardiovasc Dev Dis. 2022 May 03;9(5). PMCID: PMC9147009

99. Wang X, Kulik K, Wan TC, Lough JW, Auchampach JA. Evidence of Histone H2A.Z Deacetylation and Cardiomyocyte Dedifferentiation in Infarcted/Tip60-depleted Hearts. bioRxiv. 2024 Jan 13. PMCID: PMC10802610